| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |